Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer

Breast cancer is one of the most common malignant cancers affecting females. Estrogen receptor (ER)-positive breast cancer is responsive to endocrine therapy. Although current therapies offer favorable prospects for improving survival, the development of resistance remains a severe problem. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yan, Song, Yueshuai, Dong, Guolei, Hao, Chunfang, Zhao, Weipeng, Li, Shufen, Tong, Zhongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736845/
https://www.ncbi.nlm.nih.gov/pubmed/31506496
http://dx.doi.org/10.1038/s41598-019-49373-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736845/
https://www.ncbi.nlm.nih.gov/pubmed/31506496
http://dx.doi.org/10.1038/s41598-019-49373-w

Ejemplares similares